Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.
Cholesterol Test Market CAGR Analysis And Future Market Development
The market for cholesterol testing has experienced robust expansion lately, projected to advance from its 2025 valuation of $9.94 billion to $10.8 billion by 2026, reflecting a compound annual growth rate of 8.7%. This historical trajectory of market growth has been fueled by several key factors, including the escalating incidence of cardiovascular ailments, a heightened public understanding regarding the importance of cholesterol monitoring, the proliferation of diagnostic laboratory infrastructure, an upswing in the adoption of preventive health screenings, and the accessibility of cost-effective testing kits.
The market for cholesterol testing is projected for substantial expansion over the coming years, anticipating a valuation of $15.25 billion by 2030, fueled by a compound annual growth rate of 9.0%. This projected expansion is largely driven by a heightened need for at-home diagnostic devices, an increased emphasis on identifying diseases in their nascent stages, the proliferation of remote patient monitoring options, the growing incorporation of digital health ecosystems, and a greater embrace of customized health diagnostics. Key developments anticipated during this period involve a rise in the utilization of cholesterol testing kits designed for home use, a surge in the demand for point-of-care devices to analyze lipid levels, a more widespread application of lipid panels capable of measuring multiple indicators, the broadening scope of preventative cardiac screening initiatives, and a heightened concentration on achieving swift and precise testing outcomes.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=11968&type=smp
Cholesterol Test Market Growth Momentum: Which Factors Are Influencing Demand?
An increasing incidence of heart and blood vessel conditions, commonly known as cardiovascular diseases (CVDs), is anticipated to be a primary catalyst for the expansion of the cholesterol testing sector. These conditions encompass a spectrum of ailments such as coronary heart disease, stroke, peripheral arterial issues, and aortic afflictions, among others. A cholesterol examination serves as a critical tool, equipping both individuals and healthcare professionals with essential insights into an individual’s risk of developing heart-related ailments. Illustratively, projections from the National Institutes of Health (NIH), a United States governmental body, forecast a significant surge between 2025 and 2050, with cardiovascular disease prevalence expected to climb by 90%, mortality rates by 73%, and Disability-Adjusted Life Years (DALYs) by 55%, translating to an increase in annual deaths from 20.5 million to 35.6 million. Consequently, the escalating mortality and widespread occurrence of cardiovascular diseases are poised to significantly stimulate demand within the cholesterol test market.
Cholesterol Test Market Segmentation And Category Breakdown
The cholesterol test market covered in this report is segmented –
1) By Product Type: Test Kits, Test Strips, Other Product Types
2) By Test Type: Total Cholesterol Test, High-Density Lipoprotein (HDL) Cholesterol, Low-Density Lipoprotein (LDL) Cholesterol, Triglycerides Or Very Low-Density Lipoprotein (VLDL) Cholesterol Test
3) By Distribution Channel: Over The Counter, Prescription Based
4) By End User: Hospitals, Diagnostic Centers, Other End-Users
Subsegments:
1) By Test Kits: Home Testing Kits, Laboratory Testing Kits
2) By Test Strips: Disposable Test Strips, Multi-Use Test Strips
3) By Other Product Types: Point-Of-Care Testing Devices, Cholesterol Monitors, Reagents And Calibration Solutions
Cholesterol Test Market Trends Reshaping Industry Growth
Leading entities within the cholesterol testing arena are actively pursuing novel advancements, exemplified by the creation of blood testing systems, aimed at bolstering early identification and oversight of cholesterol metrics, thereby improving patient prognoses, facilitating tailored therapeutic approaches, and championing proactive health measures. A blood testing system represents an integrated apparatus or framework designed for the examination of blood specimens to ascertain diverse constituents, indicators, or health states. Illustratively, in the month of March in 2024, Babson Diagnostics, Inc., a health technology innovator hailing from Australia, unveiled its BetterWay system, a groundbreaking blood analysis offering incorporating the MiniDraw apparatus for gathering blood from the fingertip. This system is engineered to warm the patient’s hand, procure a minuscule blood sample using a lancet-equipped instrument, and then automatically prepare the sample, encompassing mixing and thermal adjustments, prior to dispatch to Babson’s laboratory for comprehensive examination. The BetterWay system is capable of quantifying cholesterol, analyzing blood cell differentials, and assessing liver, kidney, and thyroid functionality from an extremely small blood volume, yielding diagnostic reports within a one-to-two-day timeframe, all while amplifying patient ease and satisfaction. This methodology effectively reconciles the distinction between conventional laboratory-based diagnostic procedures and the accessibility offered at the point of care, thereby elevating the standard for routine cholesterol surveillance.
Cholesterol Test Market Competitive Analysis Of Major Industry Participants
Major companies operating in the cholesterol test market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers GmbH, Fujifilm Holdings Corporation, CVS Health Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Eurofins Scientific SE, Mindray Medical International Limited, SYNLAB International GmbH, Beckman Coulter Inc., PerkinElmer Inc., Horiba Ltd., Sigma-Aldrich Corp, Randox Laboratories Ltd., Nova Biomedical Corp, Abcam plc, Sinocare Inc., ACM Global Laboratories, Clinical Reference Laboratory Inc., Sekisui Diagnostics LLC, Everlywell Inc., SpectraCell Laboratories Inc., LetsGetChecked USA, Ulta Lab Tests LLC, Cell Biolabs Inc., BioReference Health LLC, Diazyme Laboratories Inc.
Access The Complete Cholesterol Test Market Report:
https://www.thebusinessresearchcompany.com/report/cholesterol-test-global-market-report
#Cholesterol Test Market Largest Region: Which Geography Holds The Highest Market Share?
North America was the largest region in the cholesterol test market in 2025. The regions covered in the cholesterol test market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
